Aquaporin: Induction and Role in Embryonic Ciliary Body
Principal Investigator
Jeanette Hyer, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$70,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
G2004038
Summary
A potential target of drug intervention for the treatment of glaucoma may be the aquaporin water channels found in the ciliary body of the eye. The ciliary body is the source of aqueous fluid. Aquaporins are membrane-channel proteins that are highly permeable to water, and aquaporin-1 and -4 are the major eye aquaporins expressed in the ciliary body. There is very little information on how these channels regulate their permeability to water. In previous research, Dr. Hyer demonstrated that Aquaporin-1 protein is expressed in the embryonic chick eye, which is an excellent model for eye development. She is now examining factors that lead to functional aquaporin water channels in the early development of the eye, and hopes to develop methods for reducing functional aquaporin channels in vivo. Once the requirements for aquaporin function in the eye have been determined, the chick embryo will then become a promising in-vivo model for testing the chemical and genetic interference with aquaporins.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear